INVO Reports Second Quarter 2023 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
INVO Bioscience (INVO) Tops Q2 EPS by 14c
August 14, 2023 4:20 PM EDTINVO Bioscience (NASDAQ: INVO) reported Q2 EPS of ($3.06), $0.14 better than the analyst estimate of ($3.20). Revenue for the quarter came in at $315.9 thousand versus the consensus estimate of $517 thousand.
For earnings history and earnings-related data on INVO Bioscience (INVO) click here.
... More


